BRCA突变-话题@MedSci

#BRCA突变#

32篇内容 | 3112人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1418340, encodeId=73e714183406b, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=EUR J Cancer：veliparib治疗BRCA突变的胰腺导管腺癌的II期临床试验, objectType=article, longId=124749, objectId=622e124e49ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=622e124e49ed, replyNumber=0, likeNumber=131, createdTime=2017-12-28, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=622e124e49ed, moduleTitle=EUR J Cancer：veliparib治疗BRCA突变的胰腺导管腺癌的II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=622e124e49ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418339, encodeId=50e3141833979, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=JAMA Surgery:NSM可有效降低BRCA突变人群乳腺癌风险, objectType=article, longId=114051, objectId=326b114051c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=326b114051c1, replyNumber=0, likeNumber=75, createdTime=2017-09-26, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=326b114051c1, moduleTitle=JAMA Surgery:NSM可有效降低BRCA突变人群乳腺癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=326b114051c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418338, encodeId=067c14183385b, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=Oncologist 等：肥胖类型对乳腺癌风险影响因HR状态而异/ NSM可有效降低BRCA突变人群乳腺癌风险/根据患者年龄及肿瘤分子分型预测腋窝手术强度, objectType=article, longId=114049, objectId=ca7411404999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca7411404999, replyNumber=0, likeNumber=103, createdTime=2017-09-26, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca7411404999, moduleTitle=Oncologist 等：肥胖类型对乳腺癌风险影响因HR状态而异/ NSM可有效降低BRCA突变人群乳腺癌风险/根据患者年龄及肿瘤分子分型预测腋窝手术强度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca7411404999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418337, encodeId=4707141833e05, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=JNCI：BRCA突变携带者行预防性输卵管卵巢切除术后，子宫内膜浆液性癌的发病风险降低了吗？, objectType=article, longId=111006, objectId=6d8a11100618, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d8a11100618, replyNumber=0, likeNumber=108, createdTime=2017-08-28, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d8a11100618, moduleTitle=JNCI：BRCA突变携带者行预防性输卵管卵巢切除术后，子宫内膜浆液性癌的发病风险降低了吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d8a11100618)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418336, encodeId=6c1714183362f, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=NEJM：Olaparib为有BRCA突变的转移性乳腺癌患者带来希望, objectType=article, longId=108450, objectId=b39c1084500d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b39c1084500d, replyNumber=0, likeNumber=93, createdTime=2017-08-12, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b39c1084500d, moduleTitle=NEJM：Olaparib为有BRCA突变的转移性乳腺癌患者带来希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b39c1084500d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418335, encodeId=3ccb141833595, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=ASCO2017：BRCA突变携带者进行治疗和预防联合乳房切除术的结果分析, objectType=article, longId=100894, objectId=dd7610089477, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd7610089477, replyNumber=0, likeNumber=100, createdTime=2017-06-08, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd7610089477, moduleTitle=ASCO2017：BRCA突变携带者进行治疗和预防联合乳房切除术的结果分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd7610089477)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418334, encodeId=d2fa1418334aa, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=NEJM：奥拉帕利治疗BRCA突变的转移性乳腺癌患者疗效如何？, objectType=article, longId=100831, objectId=15ac10083129, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15ac10083129, replyNumber=0, likeNumber=105, createdTime=2017-06-07, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15ac10083129, moduleTitle=NEJM：奥拉帕利治疗BRCA突变的转移性乳腺癌患者疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15ac10083129)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418333, encodeId=ffaa141833389, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=2016ESMO临床诊疗指南——BRCA突变携带者以及其他乳腺/卵巢遗传性癌症综合征的预防和筛查发布, objectType=article, longId=80002, objectId=6d9a8000242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d9a8000242, replyNumber=0, likeNumber=56, createdTime=2016-10-15, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d9a8000242, moduleTitle=2016ESMO临床诊疗指南——BRCA突变携带者以及其他乳腺/卵巢遗传性癌症综合征的预防和筛查发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d9a8000242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418332, encodeId=e1bc14183322c, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=【ASCO 2016】预告：奥拉帕利（Olaparib）和BRCA突变相关研究, objectType=article, longId=69354, objectId=61d4693540e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61d4693540e, replyNumber=0, likeNumber=72, createdTime=2016-05-29, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61d4693540e, moduleTitle=【ASCO 2016】预告：奥拉帕利（Olaparib）和BRCA突变相关研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61d4693540e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418331, encodeId=1df61418331b1, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=SABCS 2015：贝伐珠单抗新辅助治疗能显著提高BRCA突变的三阴性乳腺癌pCR率，但DFS改善有限（GeparQuinto研究）, objectType=article, longId=60903, objectId=a15260903be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a15260903be, replyNumber=0, likeNumber=86, createdTime=2015-12-22, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a15260903be, moduleTitle=SABCS 2015：贝伐珠单抗新辅助治疗能显著提高BRCA突变的三阴性乳腺癌pCR率，但DFS改善有限（GeparQuinto研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a15260903be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418330, encodeId=41e61418330f0, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=JAMA：别一刀切！不同BRCA突变致乳腺癌和卵巢癌风险不同, objectType=article, longId=49109, objectId=b2744910948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2744910948, replyNumber=0, likeNumber=95, createdTime=2015-04-10, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2744910948, moduleTitle=JAMA：别一刀切！不同BRCA突变致乳腺癌和卵巢癌风险不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2744910948)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418329, encodeId=70081418329b0, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=ASCO 2014：gBRCA突变和家族史是三阴性乳腺癌pCR高的预测因素, objectType=article, longId=36100, objectId=89703610081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89703610081, replyNumber=0, likeNumber=88, createdTime=2014-06-08, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89703610081, moduleTitle=ASCO 2014：gBRCA突变和家族史是三阴性乳腺癌pCR高的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89703610081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418328, encodeId=3299141832871, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=JEM：BRCA突变致乳腺癌和卵巢癌的发生, objectType=article, longId=21525, objectId=00cd21525e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00cd21525e8, replyNumber=0, likeNumber=0, createdTime=2013-07-18, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00cd21525e8, moduleTitle=JEM：BRCA突变致乳腺癌和卵巢癌的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00cd21525e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418327, encodeId=f246141832e63, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=Lancet Oncol：Niraparib治疗BRCA突变型散发肿瘤患者安全有效, objectType=article, longId=21400, objectId=ce8f21400c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce8f21400c7, replyNumber=0, likeNumber=100, createdTime=2013-07-17, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce8f21400c7, moduleTitle=Lancet Oncol：Niraparib治疗BRCA突变型散发肿瘤患者安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce8f21400c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418326, encodeId=20d3141832644, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=BOA2013：奥拉帕尼维持治疗可使BRCA突变性和铂敏感的复发性浆液性卵巢癌患者获益, objectType=article, longId=21190, objectId=fcdc211904f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcdc211904f, replyNumber=0, likeNumber=103, createdTime=2013-07-13, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcdc211904f, moduleTitle=BOA2013：奥拉帕尼维持治疗可使BRCA突变性和铂敏感的复发性浆液性卵巢癌患者获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcdc211904f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1418325, encodeId=0518141832565, content=<a href='/topic/show?id=39fd3e036a' target=_blank style='color:#2F92EE;'>#BRCA突变#</a>, objectTitle=JAMA：BRCA突变基因携带者预防性切除卵巢和乳房可获益预防性肿瘤切除手术能否未雨绸缪？, objectType=article, longId=2218, objectId=d7e42218a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7e42218a0, replyNumber=0, likeNumber=0, createdTime=2010-11-04, rootId=0, userName=zhanglin3080, userId=793f3344126, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7e42218a0, moduleTitle=JAMA：BRCA突变基因携带者预防性切除卵巢和乳房可获益预防性肿瘤切除手术能否未雨绸缪？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7e42218a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

BRCA突变

2020-05-29

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

EUR J Cancer：veliparib治疗BRCA突变的胰腺导管腺癌的II期临床试验

2017-12-28

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

JAMA Surgery:NSM可有效降低BRCA突变人群乳腺癌风险

2017-09-26

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

Oncologist 等：肥胖类型对乳腺癌风险影响因HR状态而异/ NSM可有效降低BRCA突变人群乳腺癌风险/根据患者年龄及肿瘤分子分型预测腋窝手术强度

2017-09-26

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

JNCI：BRCA突变携带者行预防性输卵管卵巢切除术后，子宫内膜浆液性癌的发病风险降低了吗？

2017-08-28

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

NEJM：Olaparib为有BRCA突变的转移性乳腺癌患者带来希望

2017-08-12

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

ASCO2017：BRCA突变携带者进行治疗和预防联合乳房切除术的结果分析

2017-06-08

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

NEJM：奥拉帕利治疗BRCA突变的转移性乳腺癌患者疗效如何？

2017-06-07

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

2016ESMO临床诊疗指南——BRCA突变携带者以及其他乳腺/卵巢遗传性癌症综合征的预防和筛查发布

2016-10-15

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

【ASCO 2016】预告：奥拉帕利（Olaparib）和BRCA突变相关研究

2016-05-29

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

SABCS 2015：贝伐珠单抗新辅助治疗能显著提高BRCA突变的三阴性乳腺癌pCR率，但DFS改善有限（GeparQuinto研究）

2015-12-22

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

JAMA：别一刀切！不同BRCA突变致乳腺癌和卵巢癌风险不同

2015-04-10

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

ASCO 2014：gBRCA突变和家族史是三阴性乳腺癌pCR高的预测因素

2014-06-08

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

JEM：BRCA突变致乳腺癌和卵巢癌的发生

2013-07-18

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

Lancet Oncol：Niraparib治疗BRCA突变型散发肿瘤患者安全有效

2013-07-17

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

BOA2013：奥拉帕尼维持治疗可使BRCA突变性和铂敏感的复发性浆液性卵巢癌患者获益

2013-07-13

zhanglin3080 (审核中...)

前往app查看评论内容

#BRCA突变#

JAMA：BRCA突变基因携带者预防性切除卵巢和乳房可获益预防性肿瘤切除手术能否未雨绸缪？

2010-11-04

科室
- - 订阅+
  - 更多科室
工具
服务